Company founded on probiotic for renal health branches out with prebiotic offering

By Hank Schultz contact

- Last updated on GMT

Company founded on probiotic for renal health branches out with prebiotic offering
Kibow Biotech, an R&D company founded on a novel probiotic that claims to deal with high uric acid levels, has extended its product offerings with a general probiotic supplement and most recently a multi-fiber prebiotic.

The prebiotic product, called Kibow Fortis, is a proprietary combination of two different beta glucans, inulin, XOS and arabinogalactan. The company is marketing the product for its ability to promote the growth of Lactobacillus and Bifidobacterium species as well as:

  • Supporting a healthy immune system
  • Managing healthy cholesterol levels
  • Keeping weight in check
  • Limiting hunger cravings.

The product joins two other recent offerings, called Flora, a general gut health multi-strain of probiotics, and a product called Azodyl, a probiotic/prebiotic product aimed at the renal health of dogs.

Kibow Biotech started more than 20 years ago as a research spinout from the University of Pennsylvania, where founder Natarajan Raganathan, PhD, did his post doctoral work. 

The company has spent more than the past decade bringing its novel foundational product—Renadyl—to market. This is a combination of proprietary probiotic strains cultured under propreitary conditions that Raganathan says preferentially feed on uremic toxins​. The idea is to use the vast surface area of the gut—equal to that of a tennis court—as a subsidiary kidney of sorts. The company says it has a number of patents on the technology in the US, Europe and India.

The concept is when the kidney fails, the toxins increase in the blood, and your blood flows all over your body, but the largest amount of blood flow is in your bowel,​ Raganathan said. His first idea, which he started on more than a decade ago on an NIS grant, was to genetically modify probiotic organisms for this task, but that approach ran into both technical and regulatory difficulties.

We turned around and screened various naturally occurring microbes and found some that can use these toxins,​ Raganathan said. These are naturally occurring microbes and we found out that some of these microbes had a greater capacity to utilize the uremic toxins if you grow them under proprietary conditions, or what we call uremic conditions.

Related news

Show more

Related products

show more

Innovative colic solutions

Innovative colic solutions

Recorded the 07-Jul-2022 | Webinar

Colic is one of the most frequent reasons for visits to the pediatrician and can often lead to parental and infant exhaustion. As a functional gastrointestinal...

Register for free



BIONAP BIOACTIVE NATURAL PRODUCTS | 07-Jun-2022 | Technical / White Paper

The intake of 100 mg/day of the standardized Red Orange Complex extract containing anthocyanins, hydroxycinnamic acids, flavanones, and ascorbic acid is...

Related suppliers

Follow us


View more